Indoxyl Sulfate-Mediated Metabolic Alteration of Transcriptome Signatures in Monocytes of Patients with End-Stage Renal Disease (ESRD)
End-stage renal disease (ESRD) is the final stage of chronic kidney disease, which is increasingly prevalent worldwide and is associated with the progression of cardiovascular disease (CVD). Indoxyl sulfate (IS), a major uremic toxin, plays a key role in the pathology of CVD via adverse effects in e...
Main Authors: | Hee Young Kim, Su Jeong Lee, Yuri Hwang, Ga Hye Lee, Chae Eun Yoon, Hyeon Chang Kim, Tae-Hyun Yoo, Won-Woo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/12/10/621 |
Similar Items
-
Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis
by: Jia-Fwu Shyu, et al.
Published: (2021-10-01) -
Uremic Toxin Indoxyl Sulfate Promotes Macrophage-Associated Low-Grade Inflammation and Epithelial Cell Senescence
by: Andrea Ribeiro, et al.
Published: (2023-04-01) -
Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated
by: Takuya Wakamatsu, et al.
Published: (2018-03-01) -
Cardiovascular Complications and Indoxyl Sulfate Are Related to Longer Duration of End Stage Renal Disease in Children
by: Fatina Fadel, et al.
Published: (2023-01-01) -
Indoxyl Sulfate, a Uremic Endotheliotoxin
by: Guillaume Lano, et al.
Published: (2020-04-01)